Institutional Ownership Athira Pharma, Inc. (ATHA)
This table provides information about the institutional ownership of Athira Pharma, Inc. (ATHA). We have compiled data on the 61 institutions that hold shares in the stock, with a total of 18.4 Million shares, which have been reported (via 13F filing form) to have a value of $5.15 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Perceptive Advisors LLC
New York, NY |
May 15, 2025 Q1 2025 |
5,402,964
shares
|
$1.46 Million
0.06% of portfolio
|
Q4 2023
Added 12.63%
|
|
|
Bml Capital Management, LLC
Zionsville, IN |
May 06, 2025 Q1 2025 |
3,200,667
shares
|
$864,180
0.74% of portfolio
|
Q1 2025
Added 15.3%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
May 09, 2025 Q1 2025 |
1,537,914
shares
|
$415,236
0.0% of portfolio
|
Q1 2025
Reduced 1.2%
|
|
|
Propel Bio Management, LLC
Los Angeles, CA |
May 15, 2025 Q1 2025 |
1,492,792
shares
|
$403,053
0.49% of portfolio
|
Q4 2023
New holding
|
|
|
Simplify Asset Management Inc.
New York, NY |
May 13, 2025 Q1 2025 |
1,492,792
shares
|
$403,053
0.02% of portfolio
|
Q2 2023
Added 7.38%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
676,244
shares
|
$182,585
0.0% of portfolio
|
Q2 2024
Added 1.34%
|
|
|
Tang Capital Management LLC
San Diego, CA |
May 15, 2025 Q1 2025 |
600,000
shares
|
$162,000
0.01% of portfolio
|
Q3 2024
Reduced 43.0%
|
|
|
Acadian Asset Management LLC
Boston, MA |
May 21, 2025 Q1 2025 |
428,533
shares
|
$115,703
0.0% of portfolio
|
Q1 2025
Reduced 1.37%
|
|
|
Pathstone Family Office, LLC
Englewood, NJ |
Nov 08, 2023 Q3 2023 |
425,492
shares
|
$114,882
0.01% of portfolio
|
Q3 2022
Added 7.5%
|
|
|
Bank Of America Corp
Charlotte, NC |
May 15, 2025 Q1 2025 |
416,158
shares
|
$112,362
0.0% of portfolio
|
Q1 2025
Added 0.0%
|
|
|
Pathstone Holdings, LLC
Englewood, NJ |
May 15, 2025 Q1 2025 |
372,196
shares
|
$100,492
0.0% of portfolio
|
Q4 2024
Reduced 24.37%
|
|
|
Geode Capital Management, LLC
Boston, MA |
May 13, 2025 Q1 2025 |
311,498
shares
|
$84,104
0.0% of portfolio
|
Q1 2025
Reduced 2.91%
|
|
|
Bristlecone Advisors, LLC
|
May 12, 2025 Q1 2025 |
252,200
shares
|
$68,094
0.01% of portfolio
|
Q1 2025
Reduced 25.28%
|
|
|
Qube Research & Technologies LTD
London, X0 |
May 15, 2025 Q1 2025 |
221,068
shares
|
$59,688
0.0% of portfolio
|
Q1 2025
Reduced 36.84%
|
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
May 14, 2025 Q1 2025 |
219,000
shares
|
$59,130
0.0% of portfolio
|
Q1 2025
Added 5.64%
|
|
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
May 15, 2025 Q1 2025 |
157,100
shares
|
$42,417
0.0% of portfolio
|
Q1 2025
Reduced 37.98%
|
|
|
Potomac Capital Management, Inc.
|
Feb 14, 2024 Q4 2023 |
149,585
shares
|
$40,387
0.64% of portfolio
|
Q4 2023
Added 100.56%
|
|
|
Laird Norton Trust Company, LLC
|
May 15, 2025 Q1 2025 |
127,309
shares
|
$34,373
0.01% of portfolio
|
Q4 2024
Reduced 13.58%
|
|
|
State Street Corp
Boston, MA |
May 15, 2025 Q1 2025 |
107,381
shares
|
$28,992
0.0% of portfolio
|
Q4 2024
Reduced 0.37%
|
|
|
Gsa Capital Partners LLP
London, X0 |
May 08, 2025 Q1 2025 |
88,233
shares
|
$23,822
0.0% of portfolio
|
Q1 2025
Reduced 70.25%
|
|
|
Ubs Group Ag
|
May 13, 2025 Q1 2025 |
76,551
shares
|
$20,668
0.0% of portfolio
|
Q1 2025
Reduced 11.99%
|
|
|
Northern Trust Corp
Chicago, IL |
May 13, 2025 Q1 2025 |
53,609
shares
|
$14,474
0.0% of portfolio
|
Q2 2024
Added 0.73%
|
|
|
Clarius Group, LLC
Seattle, WA |
Apr 18, 2025 Q1 2025 |
53,551
shares
|
$14,458
0.0% of portfolio
|
Q4 2023
Added 35.82%
|
|
|
Integrity Financial Corp
|
May 12, 2025 Q1 2025 |
52,902
shares
|
$14,283
0.01% of portfolio
|
Q1 2025
Added 61.36%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
May 15, 2025 Q1 2025 |
49,573
shares
|
$13,384
0.0% of portfolio
|
Q1 2025
New holding
|